Mindfulness via video could keep depression away

NCT ID NCT06832605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether mindfulness-based cognitive therapy (MBCT) delivered through video calls can prevent depression from coming back. 315 adults with recurrent depression in partial remission will be randomly assigned to group MBCT, a self-help manual with minimal video support, or usual care alone. Researchers will track who relapses over 12 months and measure costs, well-being, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mindfulness-Based Cognitive Therapy (MBCT) delivered via videoconference
What this could lead to
If successful, this could provide an effective, scalable, and cost-efficient way to prevent depression relapse using remote group therapy or self-help with minimal support.
What could go wrong
This is a behavioral intervention, not a drug, so effects may be modest. The trial is not yet recruiting, and results depend on participant engagement and therapist skill. Remote delivery may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER, RECURRENT, IN REMISSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression major depressive disorder Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Miguel Servet

    Zaragoza, Zaragoza, 50009, Spain

  • Parc Sanitari Sant Joan de Déu (PSSJD)

    Sant Boi de Llobregat, Barcelona, 08830, Spain

  • Parc de Salut Mar

    Barcelona, Barcelona, 08003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.